Spots Global Cancer Trial Database for A Study of [14C]GB491 in Male Healthy Subjects
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of [14C]GB491 in Male Healthy Subjects
Official Title: A Study of [14C]GB491 on Mass Balance and Biotransformation in Chinese Male Healthy Subjects
Study ID: NCT05860582
Interventions
Study Description
Brief Summary: This is an open-label, single-center study to evaluate the mass-balance and pharmacokinetics of GB491 in 4-8 healthy male subjects receiving a single oral 150mg dose of GB491 containing approximately 50 uCi of \[14C\]GB491. This study will help understand how the drug appears in the blood, urine, and feces after it is administered. In addition, this study will also evaluate the safety of a single dose of \[14C\]GB491 when given to healthy subjects.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: MALE
Healthy Volunteers: Yes
Locations
Beijing GoBroad Boren Hospital, Beijing, Beijing, China
Contact Details
Name: Fang HOU, Master
Affiliation: Beijing GoBroad Boren Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
